Stephens began coverage on shares of Pilgrim’s Pride (NASDAQ:PPC – Free Report) in a research note released on Thursday morning, Marketbeat.com reports. The brokerage issued an equal weight rating and a $43.00 price objective on the stock. PPC has been the topic of a number of other research reports. Barclays upped their price target on […]

JPMorgan Chase & Co. cut shares of IGM Biosciences (NASDAQ:IGMS – Free Report) from a neutral rating to an underweight rating in a research report released on Tuesday, Marketbeat reports. The brokerage currently has $9.00 target price on the stock, down from their previous target price of $12.00. Several other brokerages have also commented on […]

HC Wainwright reiterated their buy rating on shares of Gain Therapeutics (NASDAQ:GANX – Free Report) in a report published on Tuesday morning, Benzinga reports. HC Wainwright currently has a $8.00 price target on the stock. GANX has been the topic of several other research reports. Oppenheimer reiterated an outperform rating and set a $8.00 price […]

Truist Financial lowered shares of IGM Biosciences (NASDAQ:IGMS – Free Report) from a buy rating to a hold rating in a report released on Tuesday, Marketbeat Ratings reports. The firm currently has $12.00 price objective on the stock, down from their previous price objective of $24.00. IGMS has been the topic of several other research […]

StockNews.com upgraded shares of QuinStreet (NASDAQ:QNST – Free Report) from a sell rating to a hold rating in a research note issued to investors on Tuesday. QNST has been the subject of a number of other research reports. Craig Hallum boosted their target price on QuinStreet from $22.00 to $25.00 and gave the stock a […]